FDA Device Intelligence
Home › MediVena, LLC › ONE-CARE Insulin Syringes

ONE-CARE Insulin Syringes

MediVena, LLC · Model 2271 ONE-CARE Insulin Syringes 0.3ml/cc, 31g x 5/16"(8mm), 10/bg x 10, 100/bx, 4 · UDI-DI 00810008214435

FMFFMI
1
510(k) clearances
54,008
Adverse events (66 deaths)
305
Recalls
547
Facilities

Description

The ONE-CARE insulin syringe is a sterile, single-use medical device designed for the subcutaneous administration of insulin. It consists of a transparent barrel with graduated measurement markings, a fixed or detachable needle, and a plunger for precise insulin delivery. The syringe is available in multiple capacities (e.g., 0.3 mL, 0.5 mL, and 1.0 mL) with varying needle lengths and gauges to accommodate different patient needs.

Recalls

DateFirmReason
2026-04-28Mentor Texas LPA single lot of expired syringes were distributed due to a distribution system control failure.
2026-04-21ARROW INTERNATIONAL, LLCLidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited repo
2026-02-27Cardinal Health 200, LLCThe outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages
2026-01-27Becton Dickinson & CompanyDuring the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.
2025-05-23Integra LifeSciences Corp. (NeuroSciences)Lack of sterility assurance.
2025-05-22Integra LifeSciences Corp. (NeuroSciences)Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
2025-05-22Integra LifeSciences Corp. (NeuroSciences)Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
2025-05-22Integra LifeSciences Corp. (NeuroSciences)Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
2025-05-12BD SWITZERLAND SARLSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the
2025-05-12BD SWITZERLAND SARLSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.